IDL Diagnostics AB (FRA:80R) Institutional Ownership: 0.02% (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:80R IDL Diagnostics AB FRA:80R
55 GF Score
Price €0.02
GF Value €0.03
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB Institutional Ownership?

IDL Diagnostics AB FRA:80R -4.84% 55 Institutional Ownership is 0.02% as of Jul. 27, 2026. GuruFocus rates FRA:80R with a GF Score™ of 55/100 and a GF Value™ of €0.03. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IDL Diagnostics AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IDL Diagnostics AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IDL Diagnostics AB's Float Percentage Of Total Shares Outstanding is 0.00%.

IDL Diagnostics AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for IDL Diagnostics AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Diagnostics AB Institutional Ownership Chart

IDL Diagnostics AB Historical Data

The historical data trend for IDL Diagnostics AB can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02
FRA:80R
55GF Score
IDL Diagnostics AB FRA:80R
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDL Diagnostics AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
IDL Diagnostics AB (FRA:80R) has a Institutional Ownership of 0.02% as of Jul. 27, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on IDL Diagnostics AB and its competitors.
Is IDL Diagnostics AB's Institutional Ownership too high?
IDL Diagnostics AB's current Institutional Ownership is 0.02%. Overall, IDL Diagnostics AB has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does IDL Diagnostics AB's Institutional Ownership compare to TMO and DHR?
IDL Diagnostics AB's Institutional Ownership of 0.02% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on IDL Diagnostics AB and its competitors. IDL Diagnostics AB's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDL Diagnostics AB stock overvalued right now?
IDL Diagnostics AB (FRA:80R) has a current Institutional Ownership of 0.02%. The stock's GF Value™ is €0.03, compared to a current price of €0.02 — trading 21.3% below its estimated fair value. The current Institutional Ownership is 0.02%. IDL Diagnostics AB's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For IDL Diagnostics AB (FRA:80R), the current Institutional Ownership is 0.02% as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDL Diagnostics AB (FRA:80R) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of €0.02 is trading 21.3% below its estimated GF Value™ of €0.03.

Key valuation signals for FRA:80R:

  • Institutional Ownership: 0.02%
  • GF Value™: €0.03 vs. price of €0.02 (21.3% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FRA:80R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDL Diagnostics AB Business Description

Other Exchanges IDLDX:Sweden
Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for FRA:80R

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.03
GF Value